Interleukin 2 and its receptors: recent advances and new immunological functions.
about
Interleukin-2 stimulation induces tyrosine phosphorylation of p120-Cbl and CrkL and formation of multimolecular signaling complexes in T lymphocytes and natural killer cellsFree-solution, label-free molecular interactions studied by back-scattering interferometry.Mucosal delivery of murine interleukin-2 (IL-2) and IL-6 by recombinant strains of Lactococcus lactis coexpressing antigen and cytokine.Aberrant prostaglandin synthase 2 expression defines an antigen-presenting cell defect for insulin-dependent diabetes mellitusThe first alpha helix of interleukin (IL)-2 folds as a homotetramer, acts as an agonist of the IL-2 receptor beta chain, and induces lymphokine-activated killer cellsThe immunomodulatory factors of bloodfeeding arthropod saliva.Regulatory dysfunction of the interleukin-2 receptor during HIV infection and the impact of triple combination therapy.Cell receptors and cell signalling.Proteolytic cleavage of CD25, the alpha subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activityNormal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivoImmunological weapons against acute myeloid leukaemia.Interleukin-15 regulates proliferation and self-renewal of adult neural stem cellsAntibodies in the prevention of renal allograft rejection.Peripheral blood and granuloma CD4(+)CD28(-) T cells are a major source of interferon-gamma and tumor necrosis factor-alpha in Wegener's granulomatosis.Haematophagous arthropod saliva and host defense system: a tale of tear and blood.Immunomodulatory cytokines as therapeutic agents for melanomaBiomarkers of immune dysfunction following combination antiretroviral therapy for HIV infection.An Animal Model of Trichloroethylene-Induced Skin Sensitization in BALB/c Mice.Interleukin-2 Functions in Anaplastic Large Cell Lymphoma Cells through Augmentation of Extracellular Signal-Regulated Kinases 1/2 Activation.Human purified CD8+ T cells: Ex vivo expansion model to generate a maximum yield of functional cytotoxic cells.IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.Increased endosomal sorting of ligand to recycling enhances potency of an interleukin-2 analog.Interaction of STAT5 dimers on two low affinity binding sites mediates interleukin 2 (IL-2) stimulation of IL-2 receptor alpha gene transcription.T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation.Prognostic significance of soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy.IL-2, its receptors, and bcl-2 and bax genes in normal, hyperplastic and carcinomatous human prostates: immunohistochemical comparative analysis.Ipomoea obscura ameliorates cyclophosphamide-induced toxicity by modulating the immune system and levels of proinflammatory cytokine and GSH.Systemic administration of interleukin-2 inhibits inflammatory neutrophil migration: role of nitric oxide.Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.Modulation of autoimmune disease in the MRL-lpr/lpr mouse by IL-2 and TGF-beta1 gene therapy using attenuated Salmonella typhimurium as gene carrier.Cycloastragenol mediates activation and proliferation suppression in concanavalin A-induced mouse lymphocyte pan-activation model.Responses of peripheral blood mononuclear cells to moderate exercise and hypoxia.Role of IFN-gamma and IL-2 in rat lung epithelial cell migration and apoptosis after oxidant injury.Mouse brain microglia express interleukin-15 and its multimeric receptor complex functionally coupled to Janus kinase activity.IL-2 and Beyond in Cancer Immunotherapy.2-(1H-Benzimidazol-2-yl)-4,5,6,7-tetrahydro-2H-indazol-3-ol, a benzimidazole derivative, inhibits T cell proliferation involving H+/K+-ATPase inhibition.Chronic hypoxia in pregnancy affects thymus development in Balb/c mouse offspring via IL2 Signaling.Attenuation of Interleukin 2 Signal in the Spleen Cells of Complex Ganglioside-lacking MiceIL-2 triggers specific signaling pathways in human NKT cells leading to the production of pro- and anti-inflammatory cytokines
P2860
Q28261435-47D4F11F-0665-4616-911E-C42B09ABBEF2Q33299829-80456DE8-EEC0-4A41-963E-C328A8EE1B21Q33756245-9FCF0326-70F3-404C-A169-B57D93248D31Q33857220-345298BC-73B4-485E-B739-3B241754449DQ33889058-1BAA7F67-FC15-46A4-80E4-CC82157EFACEQ33962295-0AF281AD-0C22-431D-B392-741836671411Q34067437-E83B21AE-380F-4FF9-BC4B-3DE9CF66C1C5Q34148152-31705C6E-6D22-4604-AB9C-6C703BC51E25Q34452626-8FD1A2F7-7E5F-473C-B2C5-D549425C6591Q34506140-E98520A6-10D4-47C6-91EC-7FC91ED01343Q34842175-5D32FA09-2D05-492F-A37D-57D11CE3F425Q35041585-6E8F7DA5-245F-4EBF-BA96-7BC5479CDAECQ35681527-FA8644A9-B476-4655-A990-DD3B6A37B9ACQ35748061-ABCB2354-F690-45F6-A560-762C013EFD82Q36338123-9C9FCE98-A6D4-49E0-A77F-0F9902608ED2Q37070203-46219382-2FD0-4BA4-A9EE-47FF7C17A8DEQ37862747-4A36E1E1-92CC-4A4C-9D46-183C34D2DF1EQ38413995-410688A9-08DE-4FCC-8AF4-BA93D5C816D8Q39531990-45B2B492-BCFE-4E8F-AB31-42F252C9D6B4Q40190094-6DB9459A-C112-4B04-80C7-94A730663894Q40831277-182BD3C4-0A9E-417B-B688-48B618954148Q40897178-F05689BB-76B0-4CE6-BC50-27C6B3BCC0D6Q41066704-38E378CC-23F7-48CA-9989-21729B4D3421Q41105516-C18DAF6B-84AC-4223-B5B9-4FEC03A371E0Q42442672-C2144E1D-94E4-4DAB-A7FB-EBD55A6DE52AQ42494178-5DAFDAA6-60BC-40F5-974A-7D0D1560FD76Q42816478-1724A362-19C9-4DD1-8664-7B71FF04BB81Q43054090-262CA472-AF4C-43B6-8787-FBAC38866FE0Q43480803-D718F678-EDA1-4F0C-863D-9ABA377BF813Q45728999-CB5DE8DB-0B6D-4A08-9516-6D13B6881FCDQ45856448-B9A65903-A491-4BEF-B2BE-5C2102A51CD2Q46404462-575F82A1-E7DF-47F8-B6C1-A1D4AE44083EQ46660475-AE083BFB-967A-4266-B7B2-B0B1F29C3F77Q47684926-A0F02C84-57E4-41E7-A7A9-BA79D325AC92Q48596563-0CF583BE-A7AA-4344-9C09-603B6BACDD0BQ50004232-FFA51890-E52C-42A7-96FA-F854AD87574AQ53008503-E9AFD427-A2A0-492A-9F9B-53C0DEA5253FQ53163608-27FF0D8D-9B96-4264-B92F-F3A7E2A09A7BQ57539148-F49A7AA7-15A8-4A3F-97A9-E1CDD66B189FQ58040379-4697C283-932F-44E3-B729-61FBB82F7EE5
P2860
Interleukin 2 and its receptors: recent advances and new immunological functions.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Interleukin 2 and its receptors: recent advances and new immunological functions.
@ast
Interleukin 2 and its receptors: recent advances and new immunological functions.
@en
Interleukin 2 and its receptors: recent advances and new immunological functions.
@nl
type
label
Interleukin 2 and its receptors: recent advances and new immunological functions.
@ast
Interleukin 2 and its receptors: recent advances and new immunological functions.
@en
Interleukin 2 and its receptors: recent advances and new immunological functions.
@nl
prefLabel
Interleukin 2 and its receptors: recent advances and new immunological functions.
@ast
Interleukin 2 and its receptors: recent advances and new immunological functions.
@en
Interleukin 2 and its receptors: recent advances and new immunological functions.
@nl
P2093
P1433
P1476
Interleukin 2 and its receptors: recent advances and new immunological functions.
@en
P2093
P304
P356
10.1016/0167-5699(96)10057-C
P577
1996-10-01T00:00:00Z